Aspirin in the secondary prevention of unprovoked thromboembolism: the WARFASA and ASPIRE studies

Intern Emerg Med. 2013 Dec;8(8):757-60. doi: 10.1007/s11739-013-0961-7. Epub 2013 Jun 7.
No abstract available

MeSH terms

  • Anticoagulants / therapeutic use*
  • Aspirin / therapeutic use*
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Randomized Controlled Trials as Topic
  • Secondary Prevention*
  • Thromboembolism / prevention & control*
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Warfarin
  • Aspirin